Back
ProShares UltraPro S&P500 Vs. Aligos Therapeutics Industry Stock Comparison
Sell
49
UPRO
ProShares UltraPro S&P500
Last Price:
$92.93
Seasonality Move:
9.12%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
49
ProShares UltraPro S&P500 (UPRO)
is a Sell
Is ProShares UltraPro S&P500 a Buy, Sell or Hold?
-
The current ProShares UltraPro S&P500 [UPRO] share price is $95.97. The Score for UPRO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UPRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UPRO Stock Price Chart
What is ProShares UltraPro S&P500's stock price today?
-
The ProShares UltraPro S&P500 share price today is $95.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPRO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
UPRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 53.4 | Buy |
Chaikin Money Flow: | 1338149 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.6 - 98.86) | Buy |
Bollinger Bands (100): | (77.89 - 94.63) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.71 | Buy |
Relative Strength Index (14 RSI): | 81.52 | Buy |
Chaikin Money Flow: | 630913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.74 - 36.8) | Buy |
Bollinger Bands (100): | (6.83 - 25.23) | Buy |
UPRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.27 | Buy |
20-day SMA: | 96.39 | Sell |
50-day SMA: | 92.71 | Buy |
200-day SMA: | 78.92 | Buy |
8-day EMA: | 94.53 | Buy |
20-day EMA: | 94.96 | Buy |
50-day EMA: | 92.48 | Buy |
200-day EMA: | 79.7 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.61 | Buy |
20-day SMA: | 32.22 | Buy |
50-day SMA: | 20.6 | Buy |
200-day SMA: | 16.51 | Buy |
8-day EMA: | 38.12 | Buy |
20-day EMA: | 32.66 | Buy |
50-day EMA: | 24.43 | Buy |
200-day EMA: | 18.11 | Buy |
ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
ProShares UltraPro S&P500 Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |